Company Monitoring Page for Janssen

latest headlines for company on cafepharma

Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Pharmaceutical Business Review
Mon, 04/27/20 - 09:29 am
Tags:
JNJ, Janssen, FDA, Simponi Aria, polyarticular juvenile idiopathic arthritis, juvenile psoriatic arthritis
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Fierce Pharma
Mon, 03/30/20 - 10:27 am
Tags:
JNJ, Janssen, China, drug manufacturing
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
Stat
Fri, 03/27/20 - 12:10 am
Tags:
drug development, COVID-19, Italy, JNJ, Janssen, vaccines
Janssen files MS pill, ahead of FDA decision on BMS’ rival
Pharmaforum
Thu, 03/19/20 - 11:06 am
Tags:
Janssen, JNJ, multiple sclerosis, MS, FDA, ponesimod, Bristol-Myers Squibb, ozanimod
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
BioSpace
Thu, 03/12/20 - 10:52 pm
Tags:
JNJ, Janssen, Thermo Fisher, diagnostics, cancer, clinical trials
J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
BioSpace
Thu, 03/12/20 - 11:03 am
Tags:
Janssen, JNJ, FDA, JNJ-6372, breakthrough therapy, metastatic non-small cell lung cancer
Janssen gets FDA breakthrough therapy status for JNJ-6372 to treat metastatic NSCLC
Pharmaceutical Business Review
Wed, 03/11/20 - 10:26 am
Tags:
Janssen, JNJ, FDA, JNJ-6372, metastatic non-small cell lung cancer
Janssen trials ultrasound-guided approach to treating Crohn’s
Pharmaforum
Fri, 02/14/20 - 10:41 am
Tags:
JNJ, Janssen, guided ultrasound, Stelara, Crohn's Disease
Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development
Motley Fool
Tue, 02/11/20 - 11:57 pm
Tags:
JNJ, Janssen, vaccines, BARDA, HHS, coronaviruses, COVID-19
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Motley Fool
Mon, 02/10/20 - 11:32 pm
Tags:
JNJ, Janssen, Darzalex, daratumumab, Multiple Myeloma
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Pharmaceutical Business Review
Mon, 01/20/20 - 10:57 am
Tags:
Janssen, JNJ, EMA, Imbruvica, CLL
J&J, RoosterBio and Element Kick Off 2020 with Expansions
BioSpace
Mon, 01/13/20 - 11:37 pm
Tags:
JNJ, Janssen, R&D, Rooster Bio, Element Biosciences
Janssen Expands Research & Development Presence with Major Investment in South San Francisco
AP
Sat, 01/11/20 - 11:11 pm
Tags:
JNJ, Janssen, R&D, San Francisco
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Stat
Mon, 01/6/20 - 10:09 am
Tags:
Donald Trump, veterans, esketamine, major depression, Spravato, JNJ, Janssen
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
Fierce Biotech
Fri, 01/3/20 - 10:02 am
Tags:
Janssen, Provention Bio, Crohn’s disease, PRV-6527, JNJ
Digital health in 2019 – an increasingly mature sector
Pharmaforum
Thu, 01/2/20 - 11:31 pm
Tags:
digital health, Germany, Janssen, Apple, Google, FDA, Amazon
XBiotech out-licenses anti-inflammatory antibody to Janssen for up to $1.35B
Seeking Alpha
Sat, 12/7/19 - 11:55 pm
Tags:
Xbiotech, JNJ, Janssen, bermekimab
Janssen taps wearable tech in Invokana heart failure trial
Pharmaforum
Mon, 11/18/19 - 10:05 am
Tags:
JNJ, Janssen, Invokana, heart failure, wearables, real world evidence, clinial trials
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
BioSpace
Mon, 10/21/19 - 04:45 pm
Tags:
JNJ, Janssen, Stelara, FDA, ulcerative colitis
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
BioSpace
Mon, 10/21/19 - 10:00 am
Tags:
JNJ, Janssen, Tremfya, clinical trials, psoriasis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.